With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...
Cue Biopharma, Inc. CUE shares are tumbling on Wednesday after the company announced a reverse stock split. Cue Biopharma ...
Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the AACR Annual Meeting 2026, taking place April 19 ...
Company secures Commitment Letter from a leading financial institution of up to $22.5M to finance proposed acquisition ...
Thermo Fisher Scientific reported “a strong start to the year,” buoyed by strong demand from its pharma and biotech customers ...
One of Wall Street’s top firms just made the bull case for AbbVie (NYSE:ABBV | ABBV Price Prediction) stock, initiating ...
Gilead, AstraZeneca and Vertex have acquired more than just a therapeutic asset in recent deals. BioSpace takes a look at ...
Courier Health, the leading technology company for managing patient experiences, today announced it has raised a $50 million Series B funding round led by Oak HC/FT, with participation from existing ...
Meridian Funds, managed by ArrowMark Partners, released its first-quarter 2026 investor letter for “Meridian Small Cap Growth ...
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...
ESTERO, FL / ACCESS Newswire / April 15, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results